Fluphenazine enanthate is the first long-acting injectable (LAI) antipsychotic for the treatment of schizophrenia^[1][2]. In Vivo: Fluphenazine enanthate (2,4, 8 mg/kg; IM) significant inhibition of the avoidance performance is observed as long as 16, 23, and 28 days, respectively^[1].
Fluphenazine enanthate (8 mg/kg) drinking behavior is almost completely suppressed for 24 hours immediately following the administration^[1].
Fluphenazine enanthate (8 mg/kg) produces transient body weight Iosses in the rats^[1].